Nabriva Therapeutics
Earnings Date & Report
Last updated:
Nabriva Therapeutics’s last earnings date was on 22 May 2023. It reported its quarterly earnings per share (EPS) reaching -$7.77. The company’s quarterly earnings decreased by 1.03% to 7.59M US dollars compared to the same quarter of the previous year. Over the last year, Nabriva Therapeutics’s earnings per share have dropped by 55.4%.
Nabriva Therapeutics stock Earnings report, Estimates & History
| 2018-11-06 | -73.5 | -90 |
|---|---|---|
| 2019-03-12 | -81.25 | -102.5 |
| 2019-05-10 | -80.5 | -72.5 |
| 2019-08-08 | -83.75 | -75 |
| 2019-11-12 | -70.62 | -60 |
| 2020-03-12 | -83 | -72.5 |
| 2020-05-11 | -66 | -62.5 |
| 2020-08-06 | -40 | -35 |
| 2020-11-05 | -24.37 | -22.5 |
| 2021-03-11 | -23.75 | -27.75 |
| 2021-05-06 | -16.75 | -13.25 |
| 2021-08-05 | -8.67 | -7.25 |
| 2021-11-09 | -6.12 | -0.52 |
| 2022-03-29 | -4.75 | -6 |
| 2022-05-05 | -4.75 | -5 |
| 2022-08-03 | -5 | -4.5 |
| 2022-11-10 | -4.03 | -4.21 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Nabriva Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 22 May 2023 | N/A | N/A | -$7.77 | N/A | 7.59M | |
| 31 Dec 2022 | N/A | N/A | -$8.49 | N/A | 10.43M | |
| 10 Nov 2022 | Missed | -$4.03 | -$4.21 | 10.57M | 8.78M | |
| 3 Aug 2022 | Beat | -$5 | -$4.5 | N/A | 8.77M | Earnings Call Transcript |
| 5 May 2022 | Missed | -$4.75 | -$5 | 7.59M | 7.66M | |
| 29 Mar 2022 | Missed | -$4.75 | -$6 | 9.85M | 9.26M | Earnings Call Transcript |
| 10 Jan 2022 | N/A | N/A | N/A | 9.85M | 9.26M | |
| 9 Nov 2021 | Beat | -$6.12 | -$0.52 | 7.52M | 8.42M | Earnings Call Transcript |
| 5 Aug 2021 | Beat | -$8.67 | -$7.25 | 8.24M | 7.75M | Earnings Call Transcript |
| 6 May 2021 | Beat | -$16.75 | -$13.25 | 2.57M | 2.13M | |
| 11 Mar 2021 | Missed | -$23.75 | -$27.75 | N/A | 2.03M | Earnings Call Transcript |
| 5 Nov 2020 | Beat | -$24.37 | -$22.5 | 632.22K | 569K | |
| 6 Aug 2020 | Beat | -$40 | -$35 | 46.85K | -41K | |
| 11 May 2020 | Beat | -$66 | -$62.5 | 313.04K | 301K | Earnings Call Transcript |
| 12 Mar 2020 | Beat | -$83 | -$72.5 | 286.75K | 252K | Earnings Call Transcript |
| 12 Nov 2019 | Beat | -$70.62 | -$60 | 7.57M | 6.49M | Earnings Call Transcript |
| 8 Aug 2019 | Beat | -$83.75 | -$75 | N/A | N/A | |
| 10 May 2019 | Beat | -$80.5 | -$72.5 | 1.10M | 1M | |
| 12 Mar 2019 | Missed | -$81.25 | -$102.5 | N/A | N/A | |
| 6 Nov 2018 | Missed | -$73.5 | -$90 | N/A | N/A | |
Nabriva Therapeutics Earnings report FAQs
When is Nabriva Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Nabriva Therapeutics's earnings date was on 5 May 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.